Lotus Eye Hospital and Institute Limited has submitted to the Exchange, the financial results for the period ended March 31, 2026.
LOTUSEYE · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
On the reaction day the stock moved 0.7 pts less than Nifty Microcap 250 and 0.8 pts less than its Hospital peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.
Minute windows have no benchmark: there is no intraday index history to compare against.
Lotus Eye Hospital reported audited financial results for Q4 and full year ended March 31, 2026. Total income for FY26 was Rs 5,489.03 lakhs, up 7.9% from Rs 5,086.38 lakhs in FY25. Revenue from operations grew 8.4% to Rs 5,371.41 lakhs from Rs 4,956.25 lakhs. Net profit after tax for the year stood at Rs 73.93 lakhs, compared to Rs 64.33 lakhs in the previous year, representing approximately 15% PAT growth. The company achieved positive operating cash flow of Rs 301.70 lakhs. Statutory auditors issued an unmodified (clean) opinion on the financial statements. Total assets grew to Rs 8,259.74 lakhs from Rs 6,957.37 lakhs.
The company posted steady revenue and profit growth with clean audit results. However, non-current borrowings increased significantly from Rs 214.88 lakhs to Rs 1,017.40 lakhs, which shareholders should monitor for debt servicing implications.